Free Trial

Xenon Pharmaceuticals (XENE) Earnings Date, Estimates & Call Transcripts

$38.37
-0.09 (-0.23%)
(As of 05/24/2024 04:00 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(May. 9)
-$0.62 Beat By $0.07
Consensus EPS
(May. 9)
-$0.69
Skip Charts & View Estimated and Actual Earnings Data

XENE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XENE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Xenon Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.82)($0.76)($0.79)
Q2 20242($0.85)($0.79)($0.82)
Q3 20242($0.88)($0.82)($0.85)
Q4 20243($0.91)($0.73)($0.83)
FY 20249($3.46)($3.10)($3.29)

XENE Earnings Date and Information

Xenon Pharmaceuticals last announced its earnings data on May 9th, 2024. The biopharmaceutical company reported ($0.62) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.69) by $0.07. The firm earned $1 million during the quarter. Its revenue was up .0% on a year-over-year basis. Xenon Pharmaceuticals has generated ($2.71) earnings per share over the last year (($2.71) diluted earnings per share). Earnings for Xenon Pharmaceuticals are expected to decrease in the coming year, from ($2.94) to ($3.38) per share. Xenon Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.

Xenon Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2024
(Estimated)
------- 
5/9/2024Q1 2024($0.69)($0.62)+$0.07($0.62)-$1.00 million    
2/29/2024Q4 2023($0.76)($0.64)+$0.12($0.64)$2.30 million-    
11/8/2023Q3 2023($0.75)($0.73)+$0.02($0.73)$1.56 million-    
8/9/2023Q2 2023($0.69)($0.72)($0.03)($0.72)$0.46 million-    
5/9/2023Q1 2023($0.62)($0.63)($0.01)($0.63)$0.53 million-    
3/1/2023Q4 2022($0.58)($0.57)+$0.01($0.57)$2.46 million-    
11/8/2022Q3 2022($0.52)($0.57)($0.05)($0.57)$6.40 million$0.13 million
8/9/2022Q2 2022($0.49)($0.55)($0.06)($0.55)$3.25 million$0.54 million    
5/10/2022Q1 2022($0.38)($0.35)+$0.03($0.35)$9.22 million$8.77 million    
3/1/2022Q4 2021($0.47)($0.57)($0.10)($0.57)$4.20 million$3.74 million    
11/10/2021Q3 2021($0.44)($0.36)+$0.08($0.36)$7.76 million$8.12 million    
8/11/2021Q2 2021($0.49)($0.51)($0.02)($0.51)$2.58 million$2.22 million    
5/11/2021Q1 2021($0.45)($0.42)+$0.03($0.42)$3.70 million$4.36 million  
3/1/2021Q4 2020($0.40)($0.34)+$0.06($0.34)$3.50 million$5.15 million
11/5/2020Q3 2020($0.15)($0.25)($0.10)($0.25)$10.33 million$6.55 million  
5/21/2020Q1 2020($0.32)($0.22)+$0.10($0.22)$7.50 million$7.08 million  
3/9/2020Q4 2019$0.12($0.42)($0.54)($0.42)$25.00 million$3.33 million  
11/5/2019Q3($0.49)($0.33)+$0.16($0.33)-$3.50 million  
8/6/2019Q2($0.46)($0.37)+$0.09($0.37)--  

Xenon Pharmaceuticals Earnings - Frequently Asked Questions

When is Xenon Pharmaceuticals's earnings date?

Xenon Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on XENE's earnings history.

Did Xenon Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Xenon Pharmaceuticals (NASDAQ:XENE) reported ($0.62) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.69) by $0.07. Learn more on analysts' earnings estimate vs. XENE's actual earnings.

How can I listen to Xenon Pharmaceuticals's earnings conference call?

The conference call for Xenon Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Xenon Pharmaceuticals's conference call transcript?

The conference call transcript for Xenon Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does Xenon Pharmaceuticals generate each year?

Xenon Pharmaceuticals (NASDAQ:XENE) has a recorded annual revenue of $9.43 million.

How much profit does Xenon Pharmaceuticals generate each year?

Xenon Pharmaceuticals (NASDAQ:XENE) has a recorded net income of -$182.39 million. XENE has generated -$2.71 earnings per share over the last four quarters.

What is Xenon Pharmaceuticals's EPS forecast for next year?

Xenon Pharmaceuticals's earnings are expected to decrease from ($2.94) per share to ($3.38) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:XENE) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners